Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinshuibao Capsule as Add-on Therapy to ARBs for Diabetic Kidney Disease in T2DM
NCT03164785Phase 3Completed
- Sponsor
- The Second Xiangya Hospital
- Start
- Jul 2017
- Primary completion
- Sep 2020
- Modality
- HM (Herbal Medicine), FDP (Fungal-derived product)
- Countries
- 1
01
Overview
A Phase 3 trial of fermented cordyceps sinensis mycelia powder in diabetic kidney disease (DKD), type 2 diabetes mellitus (T2DM), sponsored by The Second Xiangya Hospital. Started Jul 2017; status: completed.
02
Drugs
fermented cordyceps sinensis mycelia powder
03
Conditions
diabetic kidney disease (DKD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03164785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03164785.